Patents by Inventor Mohammad Hossain
Mohammad Hossain has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20260199363Abstract: Provided are methods for treating brain tumors, characterized by an IDH1 and/or IDH2 mutation, with vorasidenib, in patients with hepatic impairment.Type: ApplicationFiled: January 13, 2025Publication date: July 16, 2026Inventors: Shuchi Pandya, Tharin Limsakun, Mohammad Hossain
-
Publication number: 20250134931Abstract: The present disclosure relates to cells capable of co-expressing T cell receptors (“TCR”) together with membrane-bound IL-15 polypeptides and/or CD8 polypeptides and the use thereof in adoptive cellular therapy. The present disclosure further provides for modified IL-15, IL-15R?, IL-15/IL-15R? fusion polypeptide, and IL-15R?/IL-15 fusion polypeptide sequences, vectors, and associated methods of making and using the same. The present disclosure further provides for modified CD8 sequences, vectors, and associated methods of making and using the same.Type: ApplicationFiled: October 30, 2024Publication date: May 1, 2025Inventors: Justin GUNESCH, Mohammad HOSSAIN, Gagan BAJWA, Melinda MATA, Mamta KALRA
-
Publication number: 20240134705Abstract: Adjusting workload execution based on workload similarity. A processor may determine a similarity of a first workload to a second workload. The processor may adjust execution of the first workload based on execution parameters of the second workload and the similarity of the first workload to the second workload.Type: ApplicationFiled: December 13, 2023Publication date: April 25, 2024Applicant: Intel CorporationInventors: Niranjan Hasabnis, Patricia Mwove, Ellick Chan, Derssie Mebratu, Kshitij Doshi, Mohammad Hossain, Gaurav Chaudhary
-
Publication number: 20230348561Abstract: The present disclosure relates to T cells capable of co-expressing T cell receptors (“TCR”) together with dominant negative TGF? Receptor (“dnTGF?R”) polypeptides and/or CD8 polypeptides and the use thereof in adoptive cellular therapy. The present disclosure further provides for dnTGF?R polypeptides, vectors, and associated methods thereof. The present disclosure further provides for modified CD8 polypeptides, vectors, and associated methods of making and using the same.Type: ApplicationFiled: April 28, 2023Publication date: November 2, 2023Inventors: Erik FARRAR, Justin GUNESCH, Melinda MATA, Mohammad HOSSAIN, Mamta KALRA, Gagan BAJWA
-
Publication number: 20230348548Abstract: The present disclosure relates to cells capable of co-expressing T cell receptors (“TCR”) together with membrane-bound IL-15 polypeptides and/or CD8 polypeptides and the use thereof in adoptive cellular therapy. The present disclosure further provides for modified IL-15, IL-15R?, IL-15/IL-15R? fusion polypeptide, and IL-15R?/IL-15 fusion polypeptide sequences, vectors, and associated methods of making and using the same. The present disclosure further provides for modified CD8 sequences, vectors, and associated methods of making and using the same.Type: ApplicationFiled: April 28, 2023Publication date: November 2, 2023Inventors: Justin GUNESCH, Mohammad HOSSAIN, Gagan BAJWA, Melinda MATA, Mamta KALRA
-
Patent number: 11701883Abstract: An electronic assembly includes a substrate having a die and PCB mounted thereon. Wirebonds interconnect bond pads of the die with contact pads of the PCB, each wirebond having a first end portion bonded to a respective bond pad, an opposite second end portion bonded to a respective contact pad and an intermediate section extending between the first and second end portions. A dam encapsulant encapsulates each of the first and second end portions, a first fill encapsulant contacts the substrate and the dam encapsulant; and a second fill encapsulant overlies the first fill encapsulant. The first fill encapsulant has a lower modulus of elasticity than the second fill encapsulant and the dam encapsulant.Type: GrantFiled: August 11, 2021Date of Patent: July 18, 2023Assignee: Memjet Technology LimitedInventors: Elmer Dimaculangan Perez, See-Huat Tan, Glenn Horrocks, Mohammad Hossain, Michael John Webb, Pascal Blanquer, Erik Coolen
-
Publication number: 20220383334Abstract: A system may provide virtual energy audits of one or more target buildings. The system may retrieve weather data and energy usage data specific to a given target building from a weather server and a utility server, respectively. The system may store predefined building characteristics corresponding to the given target building in local memory. Based on the weather data, energy usage data, and/or predefined building characteristics, the system may generate one or more building markers that characterize the energy usage and efficiency of the given target building. Building efficiency diagnostics and energy conservation prognostics may be generated based on the building markers and may be sent by the system to be displayed via a user interface of a client device. The energy conservation prognostics may include one or more energy conservation measure recommendations and corresponding predicted cost/energy savings.Type: ApplicationFiled: July 27, 2022Publication date: December 1, 2022Inventors: Alexis Abramson, Roger French, Ethan Pickering, Mohammad Hossain, Arash Khalilnejad, Rojiar Haddadian
-
Patent number: 11403647Abstract: A system may provide virtual energy audits of one or more target buildings. The system may retrieve weather data and energy usage data specific to a given target building from a weather server and a utility server, respectively. The system may store predefined building characteristics corresponding to the given target building in local memory. Based on the weather data, energy usage data, and/or predefined building characteristics, the system may generate one or more building markers that characterize the energy usage and efficiency of the given target building. Building efficiency diagnostics and energy conservation prognostics may be generated based on the building markers and may be sent by the system to be displayed via a user interface of a client device. The energy conservation prognostics may include one or more energy conservation measure recommendations and corresponding predicted cost/energy savings.Type: GrantFiled: May 10, 2019Date of Patent: August 2, 2022Assignee: Case Western Reserve UniversityInventors: Alexis Abramson, Roger French, Ethan Pickering, Mohammad Hossain, Arash Khalilnejad, Rojiar Haddadian
-
Publication number: 20220048289Abstract: An electronic assembly includes a substrate having a die and PCB mounted thereon. Wirebonds interconnect bond pads of the die with contact pads of the PCB, each wirebond having a first end portion bonded to a respective bond pad, an opposite second end portion bonded to a respective contact pad and an intermediate section extending between the first and second end portions. A dam encapsulant encapsulates each of the first and second end portions, a first fill encapsulant contacts the substrate and the dam encapsulant; and a second fill encapsulant overlies the first fill encapsulant. The first fill encapsulant has a lower modulus of elasticity than the second fill encapsulant and the dam encapsulant.Type: ApplicationFiled: August 11, 2021Publication date: February 17, 2022Inventors: Elmer Dimaculangan PEREZ, See-Huat TAN, Glenn HORROCKS, Mohammad HOSSAIN, Michael John WEBB, Pascal BLANQUER, Erik COOLEN
-
Patent number: 10449624Abstract: Methods and systems for manufacturing a three-dimensional product. Fabrication of a three-dimensional part from a powder spread over a work table as a powder bed can be initiated. The fabrication process can be paused to cool down the work table to room temperature to obtain access to the three-dimensional part for post-processing operations such as, for example, embedding external artifacts. Fabrication can continue by preheating the powder rather than the work table until fabrication of the three-dimensional part is complete. A damaged part may be placed within the powder bed, wherein the fabrication process can be directly initiated to achieve part repair. Additionally, a material of the same part's composition can be used or a different material utilized to render the part better than new. Access to the three-dimensional part allows embedding of a foreign object in the three-dimensional part within the powder bed while the three-dimensional part remains non-finished.Type: GrantFiled: September 30, 2016Date of Patent: October 22, 2019Assignee: Board of Regents, The University of Texas SystemInventors: Jorge Mireles, Mohammad Hossain, Ryan Wicker
-
Publication number: 20170258904Abstract: Inhibition of the VIP signaling pathway with VIP antagonist is contemplated. In certain embodiments, the disclosure relates to methods of enhancing the immune response to a cell therapy comprising administering a VIP antagonist to a subject in combination with a cell. In certain embodiments, the subject is diagnosed with leukemia or lymphoma. In certain embodiments, the cell is a blood cell, bone marrow cell, leukocyte, T-cell, natural killer cell, a hematopoietic stem cell, a G-CSF mobilized or non-mobilized blood mononuclear cell.Type: ApplicationFiled: May 22, 2017Publication date: September 14, 2017Inventors: Edmund K. Waller, Jian-Ming Li, Mohammad Hossain
-
Publication number: 20170095882Abstract: Methods and systems for manufacturing a three-dimensional product. Fabrication of a three-dimensional part from a powder spread over a work table as a powder bed can be initiated. The fabrication process can be paused to cool down the work table to room temperature to obtain access to the three-dimensional part for post-processing operations such as, for example, embedding external artifacts. Fabrication can continue by preheating the powder rather than the work table until fabrication of the three-dimensional part is complete. A damaged part may be placed within the powder bed, wherein the fabrication process can be directly initiated to achieve part repair. Additionally, a material of the same part's composition can be used or a different material utilized to render the part better than new. Access to the three-dimensional part allows embedding of a foreign object in the three-dimensional part within the powder bed while the three-dimensional part remains non-finished.Type: ApplicationFiled: September 30, 2016Publication date: April 6, 2017Inventors: Jorge Mireles, Mohammad Hossain, Ryan Wicker
-
Publication number: 20140102897Abstract: Disclosed herein are embodiments of an apparatus for analysis of electrochemical dissolution. One embodiment comprises a working electrode submerged in a first reaction chamber containing liquid electrolyte, a counter electrode submerged in a second reaction chamber containing liquid electrolyte, a reference electrode submerged in a third reaction chamber and electrolytically connected to the working electrode and an ion conductor electrolytically connecting the first reaction chamber and the second reaction chamber while physically separating the first reaction chamber and the second reaction chamber.Type: ApplicationFiled: October 12, 2012Publication date: April 17, 2014Applicant: NISSAN NORTH AMERICA, INC.Inventors: Gregory Jerkiewicz, Kevork Adjemian, Diane Beauchemin, Liyan Xing, Mohammad Hossain
-
Publication number: 20060073091Abstract: A direct low temperature process for lithiating hydroxides and forming lithiated transition metal oxides of suitable crystallinity. Elemental transition metal powders are combined with an aqueous solution of lithium hydroxide. The aqueous slurry solution is subject to oxidation. The resultant lithium transition metal oxide is crystallized in-situ and subsequently removed from the reactor.Type: ApplicationFiled: October 1, 2004Publication date: April 6, 2006Inventors: Feng Zou, Mohammad Hossain
-
Publication number: 20050245459Abstract: A method of utilizing the physiological activity of a rare saccharide, wherein physiological-activity sensitive cells are treated with the rare saccharide to modify the function of the cells. A composition containing, as an active ingredient, a rare saccharide which is introduced into physiological-activity sensitive cells and has an effect of modifying the function of the cells. The cells are human cells. The composition is a functional food, a drug, or a cosmetic. The rare saccharide is a rare saccharide belonging to aldose and/or ketose. The aldose is D-allose, and the cells are selected from the group consisting of cancer-cell proliferation inhibitory activity sensitive cells and active-oxygen production inhibitory activity sensitive cells. The ketose is D-psicose, and the cells are selected from the group consisting of chemokine secretion inhibitory activity sensitive cells, microglia migration inhibitory activity sensitive cells, and hypoglycemic activity sensitive cells.Type: ApplicationFiled: May 22, 2003Publication date: November 3, 2005Applicants: Fushimi Pharmaceutical Co. Ltd., Teikoku Seiyaku Co. Ltd., Kagawa University, Shikoku Research Institute Incorporated, Kabushiki Kaisha Hayashibara Seibutsu Kagaku KenkyujoInventors: Ken Izumori, Masaaki Tokuda, Toshifumi Itano, Osamu Miyamoto, Toshihiko Ishida, Koji Murao, Taizo Tasaka, Gan Muneuchi, Fuminori Yamaguchi, Terukazu Tanaka, Masaaki Ueki, Kazuyuki Hirooka, Tomohiko Taminato, Mohammad Hossain, Keiji Tsusaki, Takeo Takahashi, Mitsuhiro Nagata, Yutaka Ishida